MAPS Logo spacer
search
Bookmark and Share

MAPS Website 2.0 is now in beta-testing; please report any image issues, missing files, or broken links to askmaps@maps.org

leftspacer middlespacer rightspacer
Support Maps
R&D Medicines Menu
Featured Material
Features
Free Monthly Newsletter
small arrowMAPS Email News Archive

MAPS Bulletin
 
R&D Medicines > MAPS: MDMA Research

Long-Term Follow-Up of U.S. MDMA/PTSD Pilot Study Nears Completion

Long-Term Follow-Up of U.S. MDMA/PTSD Pilot Study Nears Completion

Our long-term follow-up to our flagship study of MDMA-assisted psychotherapy for the treatment of PTSD, which has been taking place in Charleston, SC, is coming close to completion. All that remains is for the researchers, led by Principal Investigators Michael Mithoefer, M.D. and co-therapist Ann Mithoefer, B.S.N., to collect follow-up information from a few more subjects. We’ve already obtained long-term follow-up data from 16 of the 20 subjects, at an average of about 3 ½ years after their final experimental session. The results so far are encouraging.